UBcare, the Digital Healthcare platform subsidiary of GC Biopharma, is reviewing a plan to change its name to GC MediAI to transition into an artificial intelligence (AI)-based "Medical OS" corporations.

UBcare, which holds the No. 1 share of the domestic electronic medical records (EMR) market, said on the 9th in a notice convening a shareholders meeting that it will put the name change proposal on the agenda of the regular shareholders meeting on the 24th.

The new name, GC MediAI, combines medical and AI, and carries the meaning of realizing a future medical environment based on medical expertise and AI technology.

The name change is part of a mid- to long-term strategy to make the company play the role of a "medical field operating system (Medical OS)" starting in 2026 by promoting ▲ advancement of Doctor's AI ▲ acceleration of the transition to cloud EMR ▲ expansion of data-based medical services.

UBcare plans to use this as an opportunity to shift its existing EMR-centered business structure to an AI- and cloud-based Medical OS framework. Centered on hospitals/clinics and pharmacies, it will build a medical data-based ecosystem that connects government agencies, pharmaceutical companies, insurers and financial companies, and healthcare corporations, and, based on this, expand into new medical service markets.

The company said it is pursuing the name change to more clearly establish its identity as a medical AI corporations, judging that the existing name UBcare remains tied to the image of a traditional medical IT corporations.

UBcare CEO Kim Jin-tae said, "The new name reflects the company's future strategy and direction," adding, "We will establish ourselves as a corporations leading the digital transformation of the domestic medical ecosystem."

The name change will be officially applied if it is approved at the regular shareholders meeting.

※ This article has been translated by AI. Share your feedback here.